ABOUT THE EVENT
Date: Wednesday, July 1, 2026 11am EDT
Event Location: Virtual
At ASCO 2026, China-led ADC studies reached a new milestone—outnumbering U.S.-led studies in conference presentations for the first time. Is this a one-time milestone, or the beginning of a broader shift in global oncology innovation?
To explore this question, we are excited to launch the inaugural episode of China BioPioneers · International Edition—a new online panel series dedicated to fostering deeper dialogue between Chinese innovators and global industry leaders.
Co-hosted by AsymBio, Asymchem Group, ISWTC (InScienceWeTrust Community), Healthcare Executive, and Weijieyao, the series explores the ideas, innovations, and partnerships shaping the future of biopharma.
The first panel will bring together leaders from Merck, Orum Therapeutics, XYone Therapeutics, and leading Chinese biotechs MediLink Therapeutics and Lepu Biopharma for a timely China–West discussion on ADC innovation, globalization, and the future direction of the field.
What We Will Cover
• China’s ADC Success Story: Structural Advantage or Market Timing?
• Diverging ADC Development Strategies: China vs. the West
• Manufacturing & Supply Chain: The Hidden Competitive Moat
• Globalization Playbook: From China Innovation to Global Products
• The Next Wave of ADC Innovation: Where Will the Biggest Breakthrough Come From?